- £102.56m
- £102.67m
- £33.72m
- 95
- 50
- 90
- 94
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.4 | 19.3 | 21.7 | 29.6 | 33.7 |
Cost of Revenue | |||||
Gross Profit | 11.3 | 13.2 | 14.8 | 19 | 20.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.08 | 13.6 | 15.1 | 20.3 | 24.7 |
Operating Profit | 5.35 | 5.66 | 6.63 | 9.34 | 9.04 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.48 | 5.58 | 6.67 | 9.3 | 9.12 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.5 | 4.65 | 5.32 | 7.38 | 7.41 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.5 | 4.65 | 5.32 | 7.38 | 7.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.5 | 4.65 | 5.32 | 7.38 | 7.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.111 | 0.129 | 0.159 | 0.203 | 0.195 |
Dividends per Share |